WP5010: High-Throughput DLS for Biotherapeutics Development

Antibody Charge

Assessing a drug candidate’s suitability early in the discovery and development stages is essential for minimizing the risk of costly downstream failure. Automated, high-throughput dynamic light scattering (HT–DLS) utilizing Wyatt Technology’s DynaPro® Plate Reader helps streamline the candidate selection and pre-formulation processes. HT-DLS provides more data, on more samples and more formulations—typically 10x – 30x more measurements than would be collected using cuvette-based DLS, but with far less effort.